These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31672486)

  • 1. Uncertain Etiology of Left Ventricular Hypertrophy in a Young Subject With Hypertension Treated With Dexamphetamine.
    Morselli F; Fang L; Ambrosini I; Chowienczyk PJ; Faconti L
    Am J Med; 2020 Jun; 133(6):e227-e229. PubMed ID: 31672486
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing hypertension from hypertrophic cardiomyopathy as a cause of left ventricular hypertrophy.
    Pennacchini E; Musumeci MB; Fierro S; Francia P; Autore C
    J Clin Hypertens (Greenwich); 2015 Mar; 17(3):239-41. PubMed ID: 25582947
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension.
    Snyder PS; Sadek D; Jones GL
    J Vet Intern Med; 2001; 15(1):52-6. PubMed ID: 11215913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular hypertrophy in hypertension.
    Dunn FG; Pfeffer MA
    N Engl J Med; 1999 Apr; 340(16):1279-80. PubMed ID: 10210713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arterial hypertension, left ventricular hypertrophy and antihypertensive treatment].
    de la Figuera M
    Aten Primaria; 1995 Apr; 15(6):339-40. PubMed ID: 7749022
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects.
    Oikarinen L; Viitasalo M; Toivonen L; Nieminen MS;
    J Hum Hypertens; 2001 Aug; 15 Suppl 1():S43-5. PubMed ID: 11685909
    [No Abstract]   [Full Text] [Related]  

  • 7. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
    Fogari R; Mugellini A; Destro M; Corradi L; Lazzari P; Zoppi A; Preti P; Derosa G
    Diabet Med; 2012 Jan; 29(1):24-31. PubMed ID: 21781149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
    Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
    J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of preclinical target organ damage in hypertension: left ventricular hypertrophy.
    Rosei EA;
    J Hypertens; 2002 Jan; 20(1):156-8. PubMed ID: 11791040
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Ernst ME; Davis BR; Soliman EZ; Prineas RJ; Okin PM; Ghosh A; Cushman WC; Einhorn PT; Oparil S; Grimm RH;
    J Am Soc Hypertens; 2016 Dec; 10(12):930-938.e9. PubMed ID: 27938852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left ventricular hypertrophy in patients with arterial hypertension].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Khomenko MV; Shpilevaia NI
    Lik Sprava; 1995; (7-8):68-73. PubMed ID: 8846379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the treatment with amlodipine on left ventricular hypertrophy in hypertensive patients].
    Oliván J; Moreno R; Hoyos M; Ramos E; Rodríguez A; Pizarro JL; Justo E; Pérez Cano R
    An Med Interna; 1996 Nov; 13(11):531-6. PubMed ID: 9019211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac diagnostic in hypertension].
    Ukena C; Mahfoud F; Böhm M
    MMW Fortschr Med; 2014 Jun; 156(12):51-3. PubMed ID: 25369687
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update.
    Milan A; Caserta MA; Avenatti E; Abram S; Veglio F
    Intern Emerg Med; 2010 Dec; 5(6):469-79. PubMed ID: 20480263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular hypertrophy diagnosed after a stroke: a case report.
    Umeojiako WI; Kanyal R
    J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular myocardial hypertrophy in arterial hypertension: clinical significance, diagnosis, effects of antihypertensive drugs].
    Martynov AI; Ostroumova OD; Mataev VI; Gedgafpva SIu; Il'ina SV
    Klin Med (Mosk); 2000; 78(10):10-7. PubMed ID: 11220891
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hypertensive heart: its pathogenesis, diagnosis and treatment].
    Rudyk BI; Barna ON
    Lik Sprava; 1992 May; (5):3-9. PubMed ID: 1441406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.